Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19-Reference-Cited by-同舟云学术

Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19

Published:2020-12-24 Issue:3 Volume:30 Page:699-707
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Economics

Author:

Briggs Andrew H.¹^ORCID,Goldstein Daniel A.²^ORCID,Kirwin Erin³⁴^ORCID,Meacock Rachel⁴^ORCID,Pandya Ankur⁵,Vanness David J.⁶^ORCID,Wisløff Torbjørn⁷^ORCID

Affiliation:

1. Department of Health Services Research & Policy London School of Hygiene and Tropical Medicine London UK

2. Department of Oncology, Faculty of Medicine Tel Aviv University Tel Aviv Israel

3. Institute of Health Economics Edmonton Alberta Canada

4. Health, Organisation, Policy, and Economics (HOPE) Group School of Health Sciences The University of Manchester Manchester UK

5. Department of Health Policy and Management Harvard T.H. Chan School of Public Health Boston Massachusetts USA

6. Department of Health Policy and Administration Pennsylvania State University Pennsylvania USA

7. Department of Community Medicine UiT ‐ The Arctic University of Norway Tromsø Norway

Publisher

Wiley

Subject

Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hec.4208

Reference8 articles.

1. The unequal toll of COVID‐19 mortality by age in the United States: Quantifying racial/ethnic disparities;Bassett M. T.;Harvard Centre for Population and Development Studies,2020

2. Janssen B. &Szende A.(2014).Population norms for the EQ‐5D. Chapter 3. InA.Szende B.Janssen &J.Cabases(Eds.) Self‐reported population health: An international perspective based on EQ‐5D.Amsterdam Netherlands:Springer. 978‐94‐007‐7595‐4.

3. The Effects of Diabetes, Hypertension, Asthma, Heart Disease, and Stroke on Quality-Adjusted Life Expectancy

4. COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study

5. THE COST-EFFECTIVENESS OF USING FINANCIAL INCENTIVES TO IMPROVE PROVIDER QUALITY: A FRAMEWORK AND APPLICATION

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The trade‐off between deaths by infection and socio‐economic costs in the emerging infectious disease;Population Ecology;2024-01-15

2. Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States;Vaccines;2024-01-12

3. Valuing life over the life cycle;Journal of Health Economics;2024-01

4. Exploring the impact of population ageing on the spread of emerging respiratory infections and the associated burden of mortality;BMC Infectious Diseases;2023-11-07

5. Costs and cost-effectiveness of improved nurse staffing levels and skill mix in acute hospitals: A systematic review;International Journal of Nursing Studies;2023-11